- Home
- SKIN vs TVGN Comparison
SKIN vs TVGN Comparison
Compare SKIN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKIN
- TVGN
- Stock Information
- Founded
- SKIN 1997
- TVGN 2020
- Country
- SKIN United States
- TVGN United States
- Employees
- SKIN N/A
- TVGN N/A
- Industry
- SKIN Package Goods/Cosmetics
- TVGN Blank Checks
- Sector
- SKIN Consumer Discretionary
- TVGN Finance
- Exchange
- SKIN Nasdaq
- TVGN Nasdaq
- Market Cap
- SKIN 176.3M
- TVGN 179.0M
- IPO Year
- SKIN N/A
- TVGN N/A
- Fundamental
- Price
- SKIN $1.47
- TVGN $0.53
- Analyst Decision
- SKIN Buy
- TVGN Strong Buy
- Analyst Count
- SKIN 3
- TVGN 1
- Target Price
- SKIN $2.42
- TVGN $10.00
- AVG Volume (30 Days)
- SKIN 1.1M
- TVGN 518.9K
- Earning Date
- SKIN 11-06-2025
- TVGN 11-19-2025
- Dividend Yield
- SKIN N/A
- TVGN N/A
- EPS Growth
- SKIN N/A
- TVGN N/A
- EPS
- SKIN N/A
- TVGN N/A
- Revenue
- SKIN $310,064,000.00
- TVGN N/A
- Revenue This Year
- SKIN N/A
- TVGN N/A
- Revenue Next Year
- SKIN $5.64
- TVGN N/A
- P/E Ratio
- SKIN N/A
- TVGN N/A
- Revenue Growth
- SKIN N/A
- TVGN N/A
- 52 Week Low
- SKIN $0.78
- TVGN $0.51
- 52 Week High
- SKIN $2.69
- TVGN $2.07
- Technical
- Relative Strength Index (RSI)
- SKIN 44.09
- TVGN 28.65
- Support Level
- SKIN $1.31
- TVGN $0.58
- Resistance Level
- SKIN $1.47
- TVGN $0.63
- Average True Range (ATR)
- SKIN 0.10
- TVGN 0.04
- MACD
- SKIN 0.03
- TVGN -0.01
- Stochastic Oscillator
- SKIN 71.70
- TVGN 6.25
About SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.